Miglustat effects on the basal nasal potential differences in cystic fibrosis

Journal of Cystic Fibrosis

Volumn 12, Issue 1, 2013, Pages 88-

  Jenkins, Bradlee A ^a   Glenn, L Lee ^a  

^a EAST TENNESSEE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MIGLUSTAT;

CHLORIDE TRANSPORT; CYSTIC FIBROSIS; DRUG BLOOD LEVEL; DRUG EFFECT; HUMAN; LETTER; NOSE MUCOSA;

1-DEOXYNOJIRIMYCIN; CYSTIC FIBROSIS; FEMALE; HUMANS; MALE; NASAL MUCOSA;

EID: 84870745464     PISSN: 15691993     EISSN: 18735010     Source Type: Journal    
DOI: 10.1016/j.jcf.2012.06.003     Document Type: Letter

References (3)

1. Leonard A., Lebecque P., Dingemanse J., Leal T. A randomized placebo-controlled trial of miglustat in cystic fibrosis based on nasal potential difference. J Cyst Fibros 2012, 11:231-236.
2. Trikalinos T.A., Salanti G., Zintzaras E., Ioannidis J.P. Meta-analysis methods. Adv Genet 2008, 60:311-334.
3. Baumann P., Jonzier-Perey M., Koeb L., Lê P.K., Tinguely D., Schöpf J. Amitriptyline pharmacokinetics and clinical response: I. Free and total plasma amitriptyline and nortriptyline. Int Clin Psychopharmacol 1986, 1:89-101.